Walmart beautifies Web offerings
BRISBANE, Calif. drugstore.com.—Retail giant Walmart is looking to make shopping even easier with the launch of a new at-home delivery option on thousands of health-and-beauty products purchased online—a move that undoubtedly better positions the company to go head-to-head with other online retailers of health-and-beauty aids, such as
“Customers have long trusted Walmart to provide the best values on health and beauty brands in our stores, and now customers can also access these savings online at Walmart.com with the convenience of home delivery,” stated Kelly Thompson, Walmart.com’s chief merchant. “By offering savings on our customers’ favorite health and beauty items online and in our stores, we can better help our customers shop the way they want.”
By visiting the site www.walmart.com/health, shoppers can select from thousands of health-and-beauty products—including makeup, skin care, diapers, vitamins and more—and have the items shipped to their home for 97 cents per item. Featured brands include Neutrogena, Pampers, L’Oréal, Colgate, Pantene and Gillette. Free samples of select items also are available through the Web site.
For example, Maybelline New York’s Colossal Classic Volum’ Express washable mascara is priced at less than $6, Centrum multivitamin, chewable Dora the Explorer Centrum for Kids 110-ct cost less than $10, and Sudafed PE Caplets Severe Cold Multi-Symptom 24-ct are priced at less than $6.
Hy-Vee celebrates the other white meat
WEST DES MOINES, Iowa A lot of people complain about pork barrel spending, but not Midwest supermarket chain Hy-Vee.
October is National Pork Month, and the West Des Moines, Iowa-based Hy-Vee announced Friday that sales of the meat have increased more than 25% over October 2008. The chain said it was on track to increase pork tonnage by more than 30%.
“With pork prices the lowest they’ve been in more than a decade, we’ve focused our marketing efforts on promoting pork as a great value for consumers,” Hy-Vee assistant VP meat operations Kenan Judge said in a statement. “Today’s shopper is looking for nutritious, economical meal ideas, and pork perfectly fits the bill.”
Patients prefer new diabetes drug Victoza over its competitor, survey finds
MONTREAL A new diabetes drug satisfied patients more than its competitor, according to a study funded by the drug’s manufacturer.
According to data on 379 patients who took the Diabetes Treatment Satisfaction Questionnaires, presented Thursday at the 20th World Diabetes Congress and published in medical journal The Lancet, patients taking Novo Nordisk’s drug Victoza (liraglutide) perceived less abnormally low or high blood sugar levels — known respectively as hypoglycemia and hyperglycemia — than those taking Byetta (exenatide), made by Eli Lilly & Co., Amylin Corp. and Alkermes.
Victoza is approved in Europe, but Novo Nordisk is still waiting for approval from the Food and Drug Administration in the United States.
“Liraglutide has shown here in a convincing study that it is associated with less nausea, less perceived hypoglycemia and definitely higher patient satisfaction compared to exenatide,” principal investigator Wolfgang Schmidt said in a statement. “Patient-reported outcomes data is an important extension of the efficacy data. If a patient is satisfied with his or her treatment, then they are much more likely to really stick to the treatment over the long term, which is necessary in Type 2 diabetes.”